Repligen Corporation Common Stock vs Williams-Sonoma, Inc. — how do they compare? Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B), while Williams-Sonoma, Inc. trades at $243.14 (market cap $28.26B). The key difference: Williams-Sonoma, Inc. is far larger — about 2.5× Repligen Corporation Common Stock's market cap, and Williams-Sonoma, Inc. pays a 1.27% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Williams-Sonoma, Inc. for 59 Days on average.
| RGEN | WSM | |
|---|---|---|
Market Cap | $11.14B | $28.26B |
Volume | 1,259,263 | 1,108,410 |
Sector | Health | Consumer Cyclical |
52-Week High | $194.57 | $251.81 |
52-Week Low | $102.87 | $168.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $11.02B | $28.76B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Williams-Sonoma (WSM) trades at $242.48, up 1.52% recently, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Profitability remains robust, with a net income margin of 14.73% and ROE of 54.96%, while valuation ratios like P/E of 24.61 and P/S of 3.62 reflect market confidence. Recent news highlights growth through minimal discounting and AI integration, supporting positive sentiment.
The outlook for WSM is favorable, driven by earnings momentum and market share gains, but risks include housing market sensitivity and competitive pressures. Analyst consensus leans hold with a $246.31 price target, suggesting modest upside. Institutional interest is steady, though insider selling warrants monitoring. Overall, the stock presents a balanced opportunity with growth potential tempered by sector-specific headwinds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →